Tetrabenazine-d6
Tetrabenazine-d6 (Deutetrabenazine) is a deuterium-labled Tetrabenazine (HY-B0590), is the first deuterium approved worldwide for the research of Huntington's disease, or other hyperkinetic movement disorders[1].
Product Specifications
CAS Number
[1392826-25-3]
Product Name Alternative
Deutetrabenazine; Ro 1-9569-d6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Monoamine Transporter
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Purity
99.0
Solubility
10 mM in DMSO|DMSO : 33.33mg/mL (ultrasonic) |H2O : 0.1mg/mL (ultrasonic)
Smiles
O=C1[C@H](CC(C)C)CN2CCC3=CC(OC([2H])([2H])[2H])=C(OC([2H])([2H])[2H])C=C3[C@@]2([H])C1
Molecular Formula
C19H21D6NO3
Molecular Weight
323.46
Precautions
H302, H315, H319, H335
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
